Q1 2024 Holdings
Filed 2024-05-15 | 90 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $27.6M | 1,025,000 | 0.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $28.7M | 1,142,850 | 0.9% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $29.7M | 5,785,352 | 1.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $29.9M | 480,000 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $30.6M | 710,000 | 1.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $34.4M | 431,000 | 1.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $35.1M | 799,700 | 1.1% |
| Danaher Corporation(DHR) | COM | 235851102 | $35.9M | 143,800 | 1.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $36.3M | 243,000 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $37.0M | 864,000 | 1.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $37.5M | 668,300 | 1.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $40.4M | 426,000 | 1.3% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $41.3M | 227,000 | 1.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $41.5M | 600,000 | 1.3% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $42.1M | 600,000 | 1.4% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $43.1M | 1,445,000 | 1.4% |
| CVS Health Corp(CVS) | COM | 126650100 | $43.5M | 545,000 | 1.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $43.6M | 933,500 | 1.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $46.6M | 1,174,700 | 1.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $49.8M | 217,000 | 1.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $54.5M | 70,000 | 1.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $57.4M | 2,412,500 | 1.9% |
| Align Technology Inc(ALGN) | COM | 016255101 | $62.0M | 189,000 | 2.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $63.2M | 601,000 | 2.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $63.7M | 464,100 | 2.1% |
| CG Oncology Inc(CGON) | COM | 156944100 | $63.9M | 1,454,765 | 2.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $65.4M | 68,000 | 2.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $66.2M | 502,000 | 2.1% |
| The Cigna Group(CI) | COM | 125523100 | $67.0M | 184,500 | 2.2% |
| Avantor Inc(AVTR) | COM | 05352A100 | $68.9M | 2,695,000 | 2.2% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $70.3M | 584,000 | 2.3% |
| Natera Inc(NTRA) | COM | 632307104 | $73.5M | 803,300 | 2.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $74.0M | 536,500 | 2.4% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $79.6M | 1,005,000 | 2.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $81.5M | 2,717,554 | 2.6% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $90.2M | 226,000 | 2.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $123.2M | 2,985,190 | 4.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $134.0M | 1,956,000 | 4.3% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $138.6M | 6,500,328 | 4.5% |
| Intra-Cellular Therapies Inc(ITCIEUR)Call | COM | 46116X101 | $239.5M | 600,000 | 7.7% |